CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 66 enrolled
Drug / intervention
Quadratus lumborum (QL) block group +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05444309
NCT05444309N/ACompleted

Ultrasound Guided Pericapsular Nerve Group Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Pediatric Hip Surgeries

Zagazig University·interventional·Posted Jul 5, 2022·Updated Jul 14, 2023

In Brief

A clinical study evaluating Quadratus lumborum (QL) block group and Pericapsular Nerve Group (PENG) block group for Pediatric Postoperative Pain. Completed, enrolled 66 participants across 1 site.

Detailed Summary

Hip surgeries in pediatrics consider as one of the common nowadays surgeries with sever postoperative pain so pain management is essential to decrease postoperative complications, early mobilization and hospital discharge. Traditional use of opioids is associated with many adverse effects such as sedation, dizziness, nausea, vomiting, constipation and respiratory depression. Previous studies reported that Quadratus Lumborum (QL) Block and Pericapsular Nerve Group (PENG) Block are effective postoperative analgesia in hip surgeries. In this study we will compare between QL block and PENG Block for effective postoperative analgesia to reduce opioids consumption and subsequently avoid opioid-related adverse effects, early mobilization and early hospital discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 5, 2022
Enrollment StartAug 1, 2022
Primary CompletionMay 1, 2023
Study CompletionJul 10, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.0 years ago

Interventions

Quadratus lumborum (QL) block groupprocedure

patient will receive 0.5 mg/kg of bupivacaine 0.25% through the quadratus lumborum block approach

Pericapsular Nerve Group (PENG) block groupprocedure

patient will receive 0.5 mg/kg of bupivacaine 0.25% through the Pericapsular Nerve Group (PENG) block